Washington Healthcare Update - October 2021 #2 | McGuireWood

This week in Washington: Reconciliation delayed; short-term debt ceiling fix passed.

Related Keywords

Maine , United States , New Mexico , Missouri , Texas , Washington , Kentucky , American , Melanie Anne Egorin , Mike Crapo , Xavier Becerra , Francis Collins , Johnson , Revenue Service , Senate Republicans , Us District Court , Centers For Medicare , Pfizer , Commerce Committee Health Subcommittee , Astrazeneca , Department Of Health , Departments Of Health , House Committee Leadership Write To Agencies Regarding , Health System Compounding Under Section , Taro Pharmaceuticals United States , Government Accountability Office , Medicaid Services , Murphy Request Stakeholder Input On Mental Health , Department Of Justice , Department Of Transportation , Human Services , National Institutes Of Health , Drug Administration , Drug Administration Actions On Substantial Equivalence , Health System Use Of Compounded Drugs , Medicare Coverage Of Innovative Technology , Employee Benefits Security Administration , Supreme Court , Missouri State Supreme Court , Means Committee , Office Of Personnel Management , Products Advisory Committee , Committee Leadership Write , Agencies Regarding , Murphy Request Stakeholder Input , Mental Health , Substance Use Disorder , Kevin Brady Request , Tax Credit , Medicaid Expansion , Climate Adaptation , Legislation Melanie Anne Egorin Sworn , State Based Exchanges , Three New , Partd Star , Revised Draft Guidance , Health System Use , Children Aged , Zeneca Asks , Step Down , Pharmaceutical Companie Price Fixing , Proposed Rule , Merit Based Incentive Payment , Joe Manchin , Kyrsten Sinema , Democratic House , Affordable Care , Bill Cassidy , Chris Murphy , Century Cures Act , Kevin Brady , Comptroller General , Gene Dodaro , Affordable Care Act , American Rescue , President Biden , Secretary Xavier Becerra , Legislation Melanie Anne Egorin , Commerce Committee , Health Subcommittee , House Ways , Medicare Advantage , Federal Food , Cosmetic Act , Related Biological Products Advisory Committee , National Institutes , Medicare Coverage , Innovative Technology , Personnel Management , Internal Revenue Service , Consolidated Appropriations Act , Final Rule , Rescind Trump Era , Final Rules , Premarket Review , New Tobacco , Premarket Tobacco Product Applications , Substantial Equivalence , Tobacco Product Applications , Substantial Equivalence Reports , Drug Administration Actions , Device De Novo Classification Process , Executive Order , Affordable Life Saving Medications , Surprise Billing Proposed Interim Rule , Surprise Billing ,